Growth Metrics

Astrana Health (ASTH) Receivables - Net (2016 - 2025)

Astrana Health (ASTH) has disclosed Receivables - Net for 15 consecutive years, with $374.5 million as the latest value for Q4 2025.

  • Quarterly Receivables - Net rose 35.68% to $374.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $374.5 million through Dec 2025, up 35.68% year-over-year, with the annual reading at $374.5 million for FY2025, 35.68% up from the prior year.
  • Receivables - Net hit $374.5 million in Q4 2025 for Astrana Health, down from $381.2 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $381.2 million in Q3 2025 to a low of $1.0 million in Q1 2022.
  • Historically, Receivables - Net has averaged $105.7 million across 5 years, with a median of $63.5 million in 2022.
  • Biggest five-year swings in Receivables - Net: plummeted 93.88% in 2022 and later skyrocketed 7447.67% in 2023.
  • Year by year, Receivables - Net stood at $10.6 million in 2021, then skyrocketed by 514.13% to $65.1 million in 2022, then dropped by 9.47% to $59.0 million in 2023, then soared by 367.94% to $276.0 million in 2024, then skyrocketed by 35.68% to $374.5 million in 2025.
  • Business Quant data shows Receivables - Net for ASTH at $374.5 million in Q4 2025, $381.2 million in Q3 2025, and $348.7 million in Q2 2025.